Company Overview
About Genesis Therapeutics
Genesis Therapeutics — now operating as Genesis Molecular AI — is a clinical-stage biotechnology company founded in 2019 and headquartered in Burlingame, California. The company applies artificial intelligence and machine learning to the discovery and optimization of small molecule drug candidates, with a focus on targets that have historically been considered intractable or undruggable by conventional computational chemistry approaches. Its proprietary platform, GEMS (Genesis Exploration of Molecular Space), uses deep learning to navigate the vast chemical space of possible drug-like molecules, identifying novel compounds with high predicted potency, selectivity, and drug-like properties against disease-relevant protein targets.
Business Model & Competitive Advantage
In 2025, Genesis raised $200 million in a Series B round led by Andreessen Horowitz, with participation from Fidelity Management, BlackRock, and NVIDIA''s venture capital arm — a syndicate that reflects both the biotech and AI technology investor communities. The round brought Genesis''s total funding to over $300 million. The company also announced strategic research collaborations totaling over $65 million in upfront payments with Gilead Sciences and Incyte Corporation, validating its platform in the eyes of large pharmaceutical partners.
Competitive Landscape 2025–2026
Genesis Therapeutics differentiates from other AI drug discovery companies by combining deep molecular AI with in-house chemistry and biology capabilities — enabling it to advance programs from computational hit identification through lead optimization and into IND-enabling studies without depending entirely on CRO partners. The company is building an internal pipeline of drug candidates while simultaneously pursuing pharma partnerships that provide near-term revenue and scientific validation. It competes with Recursion Pharmaceuticals, Schrödinger, Relay Therapeutics, and Insilico Medicine in the rapidly growing AI drug discovery sector, where capital deployment has increased substantially as investors bet on AI''s ability to compress drug development timelines and costs.
Key Differentiators
Strong Challenger
Genesis Therapeutics is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Numerion Labs
Numerion Labs, formerly known as Atomwise, is an AI-driven drug discovery company that uses deep learning to accelerate the identification of small molecule drug candidates. The company''s core techno
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Compare Genesis Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Genesis Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Genesis Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Genesis Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →